Loading…
HCW Biologics Inc. is projected to rise to $2.16 by 2027, a +11% move from its current price of $1.94. HCWB is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.70 | $1.94 | $2.21 | +0.13% |
| May 30 | $1.62 | $1.94 | $2.34 | +0.25% |
| May 31 | $1.55 | $1.95 | $2.44 | +0.38% |
| Jun 1 | $1.50 | $1.95 | $2.53 | +0.50% |
| Jun 2 | $1.46 | $1.95 | $2.62 | +0.63% |
| Jun 3 | $1.42 | $1.95 | $2.69 | +0.75% |
| Jun 4 | $1.38 | $1.96 | $2.77 | +0.88% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.38 | $1.96 | $2.77 | +0.88% |
| Week 2 | $1.21 | $1.97 | $3.22 | +1.77% |
| Week 3 | $1.09 | $1.99 | $3.63 | +2.66% |
| Week 4 | $1.01 | $2.01 | $4.02 | +3.56% |
| Week 5 | $0.9345 | $2.03 | $4.40 | +4.47% |
| Week 6 | $0.8756 | $2.04 | $4.77 | +5.39% |
| Week 7 | $0.8253 | $2.06 | $5.15 | +6.32% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
HCW Biologics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, HCW11-040, and HCW9302.
The company also develops HCW9201, HCW9206, and HCW11-006, and has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecules.
HCW Biologics was incorporated in 2018 and is headquartered in Miramar, Florida.
HCW Biologics Inc. trades under the symbol HCWB and is currently priced at $1.94.
Its market capitalization is $13.89M and it is ranked 5003.
Near-term price outlook is anchored by forecasts showing a 2026 average price of $1.94 with a neutral sentiment.
The 30-day range spans $0.7596 to $4.95, with a defined support at $0.308 and resistance at $2.89.
A major floor 86.2% below — a decisive break under it would weaken the trend.
The nearest floor, 84.1% below — buyers have tended to step in here.
The nearest ceiling, 49.0% above — a clean break opens room to run.
A major ceiling 121.4% above — clearing it would confirm fresh momentum.
Key HCWB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HCWB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.49 | Sell | $2.19 | Sell |
| MA 10 | $1.68 | Buy | $1.82 | Buy |
| MA 20 | $1.03 | Buy | $1.33 | Buy |
| MA 50 | $0.6723 | Buy | $0.9281 | Buy |
| MA 100 | $0.8006 | Buy | $1.15 | Buy |
| MA 200 | $2.09 | Sell | $2.96 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.65 | Neutral |
| Stoch RSI (14) | 50.34 | Neutral |
| CCI (20) | 77.39 | Neutral |
| Williams %R (14) | -36.79 | Info |
| MACD (12,26,9) | 0.20 | Buy |
| ROC (12) | 489.67 | Buy |
| Bollinger %B (20,2) | 0.75 | Neutral |
| Stochastic %K (14) | 63.21 | Neutral |
| TRIX (15) | 8.48 | Buy |
| Awesome (5,34) | 1.73 | Buy |
| Ultimate (7,14,28) | 64.26 | Neutral |
| Momentum (10) | 1.60 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 2.93 | Sell |
| ADX (14) | 33.98 | Buy |
| ATR (14) | 0.24 | Info |
The 30-day technical picture is BULLISH. RSI14 is 60, and the security trades around the moving averages, with SMA50 at $0.6723 and SMA200 at $2.09. The 30-day range is $0.7596 to $4.95, with support at $0.308 and resistance at $2.89.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.268 | $1.94 | $3.38 | 0% | Neutral | |
| $1.55 | $2.16 | $3.25 | +11% | Neutral | |
| $1.61 | $2.37 | $3.80 | +22% | Bullish | |
| $1.41 | $2.19 | $3.67 | +13% | Neutral | |
| $1.02 | $1.66 | $2.90 | -14% | Neutral | |
| $1.25 | $2.12 | $3.82 | +9% | Neutral | |
| $1.48 | $2.63 | $4.88 | +35% | Bullish | |
| $1.58 | $2.91 | $5.55 | +50% | Bullish | |
| $1.60 | $3.07 | $6.01 | +58% | Bullish | |
| $1.23 | $2.45 | $4.91 | +26% | Bullish | |
| $1.80 | $4.01 | $8.82 | +107% | Bullish | |
| $2.34 | $5.20 | $11.95 | +168% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.268 | $1.94 | $2.29 | +0.00% |
| June 2026 | $1.62 | $1.95 | $2.42 | +0.26% |
| July 2026 | $1.78 | $2.17 | $2.77 | +11.79% |
| August 2026 | $1.89 | $2.33 | $3.03 | +7.24% |
| September 2026 | $1.85 | $2.31 | $3.04 | -1.11% |
| October 2026 | $1.88 | $2.38 | $3.18 | +3.11% |
| November 2026 | $1.98 | $2.52 | $3.42 | +6.09% |
| December 2026 | $1.92 | $2.47 | $3.38 | -2.13% |
Click any year to see its month-by-month HCWB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, HCWB is projected to trade between $0.268 and $3.38, averaging $1.94 — a potential gain of 0% from today's $1.94. A consolidation phase looks the most probable path here.
HCW Biologics Inc.'s 2027 outlook centres on $2.16, within a $1.55 to $3.25 range. That is up +11% on the projected 2026 average. That marks a +11% change versus current levels. Price action looks broadly range-bound.
By 2028, HCWB could reach as high as $3.80, with a base case around $2.37 and support toward $1.61 — roughly +22% from $1.94. Buyers look set to stay in control over this stretch.
Expect HCWB to range from $1.41 to $3.67 through 2029. The $2.19 average target implies a +13% move from current prices. That is -8% versus the projected 2028 average. Price action looks broadly range-bound.
The HCWB price prediction for 2030 points to an average of $1.66 (low $1.02, high $2.90) — a potential decline of -14% on today's $1.94. A consolidation phase looks the most probable path here.
In 2031, HCWB is projected to trade between $1.25 and $3.82, averaging $2.12 — a potential gain of +9% from today's $1.94. That is up +27% on the projected 2030 average. Price action looks broadly range-bound.
HCW Biologics Inc.'s 2032 outlook centres on $2.63, within a $1.48 to $4.88 range. That is up +24% on the projected 2031 average. That marks a +35% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, HCWB could reach as high as $5.55, with a base case around $2.91 and support toward $1.58 — roughly +50% from $1.94. Momentum favours further upside here.
Expect HCWB to range from $1.60 to $6.01 through 2034. The $3.07 average target implies a +58% move from current prices. That is up +6% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The HCWB price prediction for 2035 points to an average of $2.45 (low $1.23, high $4.91) — a potential gain of +26% on today's $1.94. Momentum favours further upside here.
In 2040, HCWB is projected to trade between $1.80 and $8.82, averaging $4.01 — a potential gain of +107% from today's $1.94. That is up +63% on the projected 2035 average. Buyers look set to stay in control over this stretch.
HCW Biologics Inc.'s 2050 outlook centres on $5.20, within a $2.34 to $11.95 range. That is up +30% on the projected 2040 average. That marks a +168% change versus current levels. Momentum favours further upside here.
Investing $1,000 in HCWB today (≈ 515.463918 HCWB) could be worth
$2,678.13
+$1,678.13 (+168%) by 2050 · US Dollar
Based on the average projected HCWB price of $5.2 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HCWBwould be worth at today's price.
$1,000 invested in HCWB on May 27, 2025 (≈ 125 HCWB) would be worth
$242.5
-$757.5 (-75.8%) today · 0.24× · US Dollar
Based on a HCWB entry price of $8 vs. today's $1.94.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.43 | $798.35 | -20.2% |
| 1 month ago | $0.439 | $4,419.13 | +341.9% |
| 3 months ago | $0.55 | $3,527.27 | +252.7% |
| 6 months ago | $2.12 | $915.09 | -8.5% |
| 1 year ago | $8 | $242.5 | -75.8% |
| All time (4.9y) ago | $252 | $7.7 | -99.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HCWB forecast.
Our base-case forecast reaches $3.90 around 2040.
Implied market cap at $3.90: $27.93M
Over the multi-year horizon, the 2030 forecast shows an average price of $1.66 with ROI of -14.2% and a NEUTRAL sentiment.
In 2040 the forecast projects an average price of $4.01 with ROI of 106.6% and a BULLISH sentiment.
For 2050, the forecast envisions an average price of $5.20 with ROI of 167.8% and a BULLISH sentiment.
These are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
2030 average price is $1.66 with ROI -14.2% and sentiment NEUTRAL.
The 2026 forecast shows an average price of $1.94 with ROI 0% and sentiment NEUTRAL. Longer term, 2040 shows average $4.01 with ROI 106.6% and sentiment BULLISH, while 2050 shows average $5.20 with ROI 167.8% and sentiment BULLISH.
Yes. The forecast for 2034 shows an average price of $3.07 and a max of $6.01, with 2033 averaging $2.91, indicating that $3 can be reached in the forecast window.
Current price is $1.94 and market cap is $13.89M; rank 5003.
Sentiment is BULLISH; RSI14 is 60.0, SMA50 is $0.6723, SMA200 is $2.09. The 30-day range is $0.7596 to $4.95, with support at $0.308 and resistance at $2.89.
HCW Biologics Inc. Community Discussion
0Share your HCW Biologics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.